Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway

<tt>edgeR</tt> : a Bioconductor package for differential expression analysis of digital gene expression data

Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · see citing works

Methods in Yeast Genetics

Jacob, H. (1988) · Bioelectrochemistry and Bioenergetics · doi:10.1016/0302-4598(88)80052-7 · Cited by 4,911 · see citing works

Hidden Killers: Human Fungal Infections

Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · see citing works

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Chomont, N., Far, M. E., Ancuța, P., Trautmann, L., Procopio, F. A., Yassine‐Diab, B., Boucher, G., Boulassel, M., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,709 · see citing works

Biofilm Formation by the Fungal Pathogen <i>Candida albicans</i> : Development, Architecture, and Drug Resistance

Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578 · see citing works

A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing

Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L., Mowat, E., Ramage, G., & Lopez-Ribot, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.141 · Cited by 1,041 · see citing works

Gold-Based Therapeutic Agents

Shaw, C. F. (1999) · Chemical Reviews · doi:10.1021/cr980431o · Cited by 992 · see citing works

Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment

Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903 · see citing works

A Disulfide Relay System in the Intermembrane Space of Mitochondria that Mediates Protein Import

Mesecke, N., Terziyska, N., Kozany, C., Baumann, F., Neupert, W., Hell, K., & Herrmann, J. M. (2005) · Cell · doi:10.1016/j.cell.2005.04.011 · Cited by 557 · see citing works

Antifungal Resistance and New Strategies to Control Fungal Infections

Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 507 · see citing works

Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast

Giaever, G. N., Flaherty, P., Kumm, J., Proctor, M. J., Nislow, C., Jaramillo, D. F., Chu, A. M., Jordan, M. I., Arkin, A. P., & Davis, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307490100 · Cited by 506 · see citing works

Gold compounds as therapeutic agents for human diseases

Berners‐Price, S. J., & Filipovska, A. (2011) · Metallomics · doi:10.1039/c1mt00062d · Cited by 496 · see citing works

Antifungal drug resistance among <i>Candida</i> species: mechanisms and clinical impact

Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394 · see citing works

Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target

Kuntz, A. N., Davioud–Charvet, E., Sayed, A. A., Califf, L. L., Dessolin, J., Arnér, E. S. J., & Williams, D. L. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040206 · Cited by 367 · see citing works

Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis

Mylonakis, E. E., Ausubel, F. M., Perfect, J. R., Heitman, J., & Calderwood, S. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232568599 · Cited by 330 · see citing works

Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis

Harbut, M. B., Vilchèze, C., Luo, X., Hensler, M. E., Guo, H., Yang, B., Chatterjee, A. K., Nizet, V., Jacobs, W. R., Schultz, P. G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504022112 · Cited by 329 · see citing works

Mechanisms of echinocandin antifungal drug resistance

Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313 · see citing works

[14] Isolation of highly purified mitochondria from Saccharomyces cerevisiae

Glick, B. S., & Pon, L. A. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)60139-2 · Cited by 309 · see citing works

A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target

Debnath, A., Parsonage, D., Andrade, R. M., He, C., Cobo, E. R., Hirata, K. K., Chen, S., García‐Rivera, G., Orozco, E., Martínez, M. B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2758 · Cited by 307 · see citing works

Quantitative phenotyping via deep barcode sequencingPreprint

Smith, A. M., Heisler, L. E., Mellor, J. C., Kaper, F., Thompson, M. J., Chee, M. S., Roth, F. P., Giaever, G. N., & Nislow, C. (2009) · Genome Research · doi:10.1101/gr.093955.109 · Cited by 297 · see citing works

Recent insights into Candida albicans biofilm resistance mechanisms

Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271 · see citing works

Mapping the Cellular Response to Small Molecules Using Chemogenomic Fitness Signatures

Spear, E. D., & Kaiser, C. A. (2013) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 266 · see citing works

MIA40 is an oxidoreductase that catalyzes oxidative protein folding in mitochondria

Banci, L., Bertini, I., Cefaro, C., Ciofi‐Baffoni, S., Gallo, A., Martinelli, M., Sideris, D. P., Katrakili, N., & Tokatlidis, K. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1553 · Cited by 261 · see citing works

Mapping the Cellular Response to Small Molecules Using Chemogenomic Fitness Signatures

Lee, A. Y., St.Onge, R. P., Proctor, M. J., Wallace, I. M., Nile, A. H., Spagnuolo, P. A., Jitkova, Y., Gronda, M., Wu, Y., Kim, M. K., et al. (2014) · Science · doi:10.1126/science.1250217 · Cited by 241 · see citing works

Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin

Angelucci, F., Sayed, A. A., Williams, D. L., Boumis, G., Brunori, M., Dimastrogiovanni, D., Miele, A. E., Pauly, F., & Bellelli, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020701 · Cited by 214 · see citing works

Characterization of Mucosal Candida albicans Biofilms

Dongari‐Bagtzoglou, A. I., Kashleva, H., Dwivedi, P., Diaz, P. I., & Vasilakos, J. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007967 · Cited by 212 · see citing works

Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens

Thangamani, S., Mohammad, H. T., Abushahba, M. F. N., Sobreira, T. J. P., Hedrick, V., Paul, L. N., & Seleem, M. N. (2016) · Scientific Reports · doi:10.1038/srep22571 · Cited by 210 · see citing works

The disulfide relay system of mitochondria is connected to the respiratory chain

Bihlmaier, K., Mesecke, N., Terziyska, N., Bien, M., Hell, K., & Herrmann, J. M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200707123 · Cited by 207 · see citing works

A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition

Ilari, A., Baiocco, P., Luigi Messori, A., Fiorillo, A., Boffi, A., GRAMICCIA, M., Muccio, T. D., & Colotti, G. (2011) · Amino Acids · doi:10.1007/s00726-011-0997-9 · Cited by 190 · see citing works

Antifungal Drug Discovery: Something Old and Something New

Butts, A., & Krysan, D. J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002870 · Cited by 182 · see citing works

Update on Antifungal Drug Resistance

Perlin, D. S., Shor, E., & Zhao, Y. (2015) · Current Clinical Microbiology Reports · doi:10.1007/s40588-015-0015-1 · Cited by 174 · see citing works

New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro : Mechanistic and pharmacological implications

Sannella, A. R., Casini, A., Gabbiani, C., Luigi Messori, A., Bilia, A. R., Vincieri, F., Majori, G., & Severini, C. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.028 · Cited by 172 · see citing works

Candida Biofilms: Development, Architecture, and Resistance

Chandra, J., & Mukherjee, P. K. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0020-2015 · Cited by 169 · see citing works

A role for cytochrome c and cytochrome c peroxidase in electron shuttling from Erv1

Dabir, D. V., Leverich, E. P., Kim, S., Tsai, F. D., Hirasawa, M., Knaff, D. B., & Koehler, C. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601909 · Cited by 162 · see citing works

The Essential Mitochondrial Protein Erv1 Cooperates with Mia40 in Biogenesis of Intermembrane Space Proteins

Rissler, M., Wiedemann, N., Pfannschmidt, S., Gabriel, K., Guiard, B., Pfanner, N., & Chacińska, A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.08.051 · Cited by 156 · see citing works

A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia

Tejman-Yarden, N., Miyamoto, Y., Leitsch, D., Santini, J., Debnath, A., Gut, J., McKerrow, J. H., Reed, S. L., & Eckmann, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01675-12 · Cited by 144 · see citing works

Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp

da Silva, A. R., de Andrade Neto, J. B., da Silva, C. R., Campos, R. D. S., Costa Silva, R. A., Freitas, D. D., do Nascimento, F. B. S. A., de Andrade, L. N. D., Sampaio, L. S., Grangeiro, T. B., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01846-15 · Cited by 139 · see citing works

Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent

Thangamani, S., Mohammad, H. T., Abushahba, M. F. N., Hamed, M. I., Sobreira, T. J. P., Hedrick, V., Paul, L. N., & Seleem, M. N. (2015) · Scientific Reports · doi:10.1038/srep16407 · Cited by 138 · see citing works

Bugs, drugs and chemical genomics

Roemer, T., DAVIES, J. E., Giaever, G. N., & Nislow, C. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.744 · Cited by 121 · see citing works

Patterns of Amphotericin B Killing Kinetics against Seven Candida Species

Cantón, E., Pemán, J., Gobernado, M., Viudes, A., & Espinel‐Ingroff, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2477-2482.2004 · Cited by 119 · see citing works

Dual function of a new nuclear gene for oxidative phosphorylation and vegetative growth in yeast

Lisowsky, T. (1992) · Molecular and General Genetics MGG · doi:10.1007/bf00299137 · Cited by 117 · see citing works

Platyhelminth Mitochondrial and Cytosolic Redox Homeostasis Is Controlled by a Single Thioredoxin Glutathione Reductase and Dependent on Selenium and Glutathione

Bonilla, M., Denicola, A., Novoselov, S. V., Turanov, A. A., Protasio, A. V., Izmendi, D., Gladyshev, V. N., & Salinas, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710609200 · Cited by 103 · see citing works

Selenium metabolism in Trypanosoma: characterization of selenoproteomes and identification of a Kinetoplastida-specific selenoprotein

Lobanov, A. V., Gromer, S., Salinas, G., & Gladyshev, V. N. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl541 · Cited by 101 · see citing works

Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension

Lewis, M. G., DaFonseca, S., Chomont, N., Palamara, A. T., Tardugno, M., Mai, A., Collins, M., Wagner, W., Yalley-Ogunro, J., Greenhouse, J. J., et al. (2011) · AIDS · doi:10.1097/qad.0b013e328347bd77 · Cited by 92 · see citing works

A Small Molecule Inhibitor of Redox-Regulated Protein Translocation into Mitochondria

Dabir, D. V., Hasson, S. A., Setoguchi, K., Johnson, M. E., Wongkongkathep, P., Douglas, C. J., Zimmerman, J., Damoiseaux, R. D., Teitell, M. A., & Koehler, C. M. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.03.006 · Cited by 92 · see citing works

Repurposing celecoxib as a topical antimicrobial agent

Thangamani, S., Younis, W., & Seleem, M. N. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00750 · Cited by 91 · see citing works

Repurposing auranofin for the treatment of cutaneous staphylococcal infections

Thangamani, S., Mohammad, H. T., Abushahba, M. F. N., Sobreira, T. J. P., & Seleem, M. N. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.12.016 · Cited by 91 · see citing works

Using Galleria mellonella–Candida albicans Infection Model to Evaluate Antifungal Agents

Li, D., Deng, L., Hu, G.-H., Zhao, L., Hu, D., Jiang, Y., & Wang, Y. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00270 · Cited by 89 · see citing works

Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au–Se adduct

Jackson-Rosario, S., Cowart, D. M., Myers, A. G., Tarrien, R. J., Levine, R. L., Scott, R. A., & Self, W. T. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0466-z · Cited by 86 · see citing works

Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections

Cassetta, M. I., Marzo, T., Fallani, S., Novelli, A., & Luigi Messori, A. (2014) · BioMetals · doi:10.1007/s10534-014-9743-6 · Cited by 84 · see citing works

X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action

Parsonage, D., Sheng, F., Hirata, K. K., Debnath, A., McKerrow, J. H., Reed, S. L., Abagyan, R. A., Poole, L. B., & Podust, L. M. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2016.02.015 · Cited by 78 · see citing works

Auranofin efficacy against MDRStreptococcus pneumoniaeandStaphylococcus aureusinfections

Aguinagalde, L., Díez‐Martínez, R., Yuste, J., Royo, I., Gil, C., Lasa, Í., Martín‐Fontecha, M., Marín‐Ramos, N. I., Ardanuy, C., Liñares, J., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv163 · Cited by 71 · see citing works

Antifungal Application of Nonantifungal Drugs

Stylianou, M., Kulesskiy, E., Lopes, J. P., Granlund, M., Wennerberg, K., & Urban, C. F. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01087-13 · Cited by 71 · see citing works

Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens

Thangamani, S., Younis, W., & Seleem, M. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133877 · Cited by 68 · see citing works

Auranofin Is an Apoptosis-Simulating Agent within Vitroandin VivoAnti-leishmanial Activity

Sharlow, E. R., Leimgruber, S., Murray, S., Lira, A., Sciotti, R. J., Hickman, M. R., Hudson, T., Leed, S. E., Caridha, D. P., Barrios, A. M., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400800q · Cited by 68 · see citing works

Mechanism of Action, Pharmacology, Clinical Efficacy and Side Effects of Auranofin: An Orally Administered Organic Gold Compound for the Treatment of Rheumatoid Arthritis

Fürst, D. E. (1983) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1983.tb03277.x · Cited by 66 · see citing works

Inhibition of Bacterial and Fungal Pathogens by the Orphaned Drug Auranofin

Fuchs, B. B., Rajamuthiah, R., Souza, A. C. R., Eatemadpour, S., Rossoni, R. D., Santos, D. A., Junqueira, J. C., Rice, L. B., & Mylonakis, E. E. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.182 · Cited by 62 · see citing works

A candidate anti-HIV reservoir compound, auranofin, exerts a selective ‘anti-memory’ effect by exploiting the baseline oxidative status of lymphocytes

Chirullo, B., Sgarbanti, R., Limongi, D., Shytaj, I. L., Alvarez, D., Das, B., Boe, A., DaFonseca, S., Chomont, N., Liotta, L. A., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.473 · Cited by 60 · see citing works

Drug Repurposing for the Treatment of Staphylococcal Infections

Thangamani, S., Mohammad, H. T., Younis, W., & Seleem, M. N. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150310104416 · Cited by 58 · see citing works

Auranofin and related heterometallic gold(I)–thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains

Hokai, Y., Jurkowicz, B., Fernández‐Gallardo, J., Zakirkhodjaev, N., Sanaú, M., Muth, T. R., & Contel, M. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.05.008 · Cited by 57 · see citing works

Investigation of a potential mechanism for the inhibition of SmTGR by Auranofin and its implications for Plasmodium falciparum inhibition

Caroli, A., Simeoni, S., Lepore, R., Tramontano, A. L., & Via, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.009 · Cited by 41 · see citing works

Substrate specificity of the TIM22 mitochondrial import pathway revealed with small molecule inhibitor of protein translocation

Hasson, S. A., Damoiseaux, R. D., Glavin, J. D., Dabir, D. V., Walker, S. S., & Koehler, C. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914387107 · Cited by 40 · see citing works

Treatment of HIV associated psoriatic arthritis with oral gold.

Shapiro, D. L., & Masci, J. R. (1996) · PubMed · Cited by 32 · see citing works

Role of Twin Cys-Xaa9-Cys Motif Cysteines in Mitochondrial Import of the Cytochrome c Oxidase Biogenesis Factor Cmc1

Bourens, M., Dabir, D. V., Tienson, H. L., Sorokina, I., Koehler, C. M., & Barrientos, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.383562 · Cited by 27 · see citing works

In Vitro Analyses of Ethanol Activity against Candida albicans Biofilms

Rane, H. S., Bernardo, S. M., Walraven, C. J., & Lee, S. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00263-12 · Cited by 25 · see citing works

Auranofin therapy in rheumatoid arthritis.

Gc, B. (1982) · PubMed · Cited by 24 · see citing works

Evidence that the antiproliferative effects of auranofin in Saccharomyces cerevisiae arise from inhibition of mitochondrial respiration

Gamberi, T., Fiaschi, T., Modesti, A., Massai, L., Luigi Messori, A., Balzi, M., & Magherini, F. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.016 · Cited by 18 · see citing works

Mia40 Protein Serves as an Electron Sink in the Mia40-Erv1 Import Pathway

Neal, S. E., Dabir, D. V., Tienson, H. L., Horn, D. M., Glaeser, K., Loo, R. R. O., Barrientos, A., & Koehler, C. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.669440 · Cited by 16 · see citing works

Antifungal drugs: New insights in research & development

Nicola, A. M., Albuquerque, P., Paes, H. C., Fernandes, L., Costa, F. F., Kioshima, É. S., Abadio, A. K. R., Bocca, A. L., & Felipe, M. S. S. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.008 · Cited by 143 · see citing works

Emerging New Targets for the Treatment of Resistant Fungal Infections

Liu, N., Tu, J., Dong, G., Wang, Y., & Sheng, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01413 · Cited by 129 · see citing works

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms

Dijck, P. V., Sjollema, J., Cammue, B. P. A., Lagrou, K., Berman, J. G., d’Enfert, C., Andes, D. R., Arendrup, M. C., Brakhage, A. A., Calderone, R., et al. (2018) · Microbial Cell · doi:10.15698/mic2018.07.638 · Cited by 129 · see citing works

Development and research progress of anti-drug resistant fungal drugs

Cui, X., Wang, L., Lü, Y., & Yue, C. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.08.004 · Cited by 85 · see citing works

Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System

May, H. C., Yu, J., Guentzel, M. N., Chambers, J. P., Cap, A. P., & Arulanandam, B. P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00336 · Cited by 82 · see citing works

Recent Advances of Gold Compounds in Anticancer Immunity

Yue, S., Luo, M., Liu, H., & Wei, S. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00543 · Cited by 84 · see citing works

Antibacterial and antivirulence activities of auranofin against Clostridium difficile

AbdelKhalek, A., Abutaleb, N. S., Mohammad, H. T., & Seleem, M. N. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.09.018 · Cited by 78 · see citing works

Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci

AbdelKhalek, A., Abutaleb, N. S., Elmagarmid, K. A., & Seleem, M. N. (2018) · Scientific Reports · doi:10.1038/s41598-018-26674-0 · Cited by 73 · see citing works

Antifungal Drug Repurposing

Kim, J. H., Cheng, L. W., Chan, K. L., Tam, C. C., Mahoney, N., Friedman, M., Shilman, M. M., & Land, K. M. (2020) · Antibiotics · doi:10.3390/antibiotics9110812 · Cited by 71 · see citing works

Exploring and exploiting the connection between mitochondria and the virulence of human pathogenic fungi

Verma, S., Shakya, V. P. S., & Idnurm, A. (2018) · Virulence · doi:10.1080/21505594.2017.1414133 · Cited by 67 · see citing works

Combination Therapy to Treat Fungal Biofilm-Based Infections

Tits, J., Cammue, B. P. A., & Thevissen, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228873 · Cited by 70 · see citing works

Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae

Elkashif, A., & Seleem, M. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-62696-3 · Cited by 64 · see citing works

Metallodrug binding to serum albumin: Lessons from biophysical and structural studies

Merlino, A. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215026 · Cited by 62 · see citing works

Reactions of Auranofin and Its Pseudohalide Derivatives with Serum Albumin Investigated through ESI-Q-TOF MS

Pratesi, A., Cirri, D., Ciofi, L., & Luigi Messori, A. (2018) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.8b02177 · Cited by 56 · see citing works

Identification of a Phenylthiazole Small Molecule with Dual Antifungal and Antibiofilm Activity Against Candida albicans and Candida auris

Mohammad, H. T., Eldesouky, H. E., Hazbun, T. R., Mayhoub, A. S., & Seleem, M. N. (2019) · Scientific Reports · doi:10.1038/s41598-019-55379-1 · Cited by 54 · see citing works

Molecular mechanisms and clinical implications of the gold drug auranofin

Shen, S., Shen, J. M., Luo, Z. Y., Wang, F., & Min, J. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215323 · Cited by 50 · see citing works

Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial

Diaz, R. S., Shytaj, I. L., Giron, L. B., Obermaier, B., Líbera, E. D., Galinskas, J., Dias, D., Hunter, J., Janini, L. M., Gosuen, G. C., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.08.001 · Cited by 50 · see citing works

Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and <i>Candida</i> spp

Rossi, S. A., de Oliveira, H. C., Agreda-Mellon, D., Lucio, J., Mendes-Giannini, M. J. S., García-Cambero, J. P., & Zaragoza, O. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01921-19 · Cited by 48 · see citing works

Broad-spectrum antifungal activity of spirooxindolo-pyrrolidine tethered indole/imidazole hybrid heterocycles against fungal pathogens

Bolous, M., Arumugam, N., Almansour, A. I., Kumar, R. S., Maruoka, K., Antharam, V. C., & Thangamani, S. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.07.022 · Cited by 48 · see citing works

Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection

Abutaleb, N. S., & Seleem, M. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-64882-9 · Cited by 47 · see citing works

Fungal Mitogenomes: Relevant Features to Planning Plant Disease Management

Medina, R., Franco, M. E. E., Bartel, L. C., Alcántara, V. M., Saparrat, M. C. N., & Balatti, P. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00978 · Cited by 43 · see citing works

Emerging and future strategies in the management of recalcitrant Candida auris

Bandara, N., & Samaranayake, L. P. (2022) · Medical Mycology · doi:10.1093/mmy/myac008 · Cited by 42 · see citing works

Antifungal activity of vitamin D3 against Candida albicans in vitro and in vivo

Lei, J., Xiao, W., Zhang, J., Liu, F., Xin, C., Zhou, B., Chen, W., & Song, Z. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127200 · Cited by 39 · see citing works

Repurposing Fenamic Acid Drugs To Combat Multidrug-Resistant Neisseria gonorrhoeae

Seong, Y. J., Alhashimi, M., Mayhoub, A. S., Mohammad, H. T., & Seleem, M. N. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02206-19 · Cited by 39 · see citing works

Repurposing Salicylamide for Combating Multidrug-Resistant Neisseria gonorrhoeae

Alhashimi, M., Mayhoub, A. S., & Seleem, M. N. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01225-19 · Cited by 38 · see citing works

Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of<i>Candida auris</i>and displays potent synergistic interactions with azole drugs

Eldesouky, H. E., Lanman, N. A., Hazbun, T. R., & Seleem, M. N. (2020) · Virulence · doi:10.1080/21505594.2020.1838741 · Cited by 37 · see citing works

Benzimidazole tethered pyrrolo[3,4-b]quinoline with broad-spectrum activity against fungal pathogens

Villa, P., Arumugam, N., Almansour, A. I., Kumar, R. S., Mahalingam, S. M., Maruoka, K., & Thangamani, S. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.01.006 · Cited by 37 · see citing works

Antibiofilm efficacy of the gold compound auranofin on dual species biofilms ofStaphylococcus aureusandCandidasp.

She, P., Liu, Y., Wang, Y., Tan, F., Luo, Z., & Wu, Y. C. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14443 · Cited by 37 · see citing works

Distorted Gold(I)–Phosphine Complexes as Antifungal Agents

Dennis, E. K., Kim, J. H., Parkin, S., Awuah, S. G., & Garneau‐Tsodikova, S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01436 · Cited by 36 · see citing works

Gold( iii ) bis(dithiolene) complexes: from molecular conductors to prospective anticancer, antimicrobial and antiplasmodial agents

Fontinha, D., Sousa, S. A., Morais, T. S., Prudêncio, M., Leitão, J. H., Gal, Y. L., Lorcy, D., Silva, R. A. L., Velho, M. F. G., Belo, D., et al. (2020) · Metallomics · doi:10.1039/d0mt00064g · Cited by 36 · see citing works

On the path to gold: Monoanionic Au bisdithiolate complexes with antimicrobial and antitumor activities

Sousa, S. A., Leitão, J. H., Silva, R. A. L., Belo, D., Santos, I. C., Guerreiro, J. F., Martins, M., Fontinha, D., Prudêncio, M., Almeida, M., et al. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110904 · Cited by 30 · see citing works

Discovery of a Novel Dibromoquinoline Compound Exhibiting Potent Antifungal and Antivirulence Activity That Targets Metal Ion Homeostasis

Mohammad, H., Elghazawy, N. H., Eldesouky, H. E., Hegazy, Y. A., Younis, W., Avrimova, L., Hazbun, T., Arafa, R. K., & Seleem, M. N. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00215 · Cited by 29 · see citing works

A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis

Coelho, R. A., Joffe, L. S., Alves, G. M., Figueiredo‐Carvalho, M. H. G., Brito‐Santos, F., Amaral, A. C. F., Rodrigues, M. L., & Almeida‐Paes, R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229630 · Cited by 29 · see citing works

Auranofin is an Effective Agent against Clinical Isolates of Staphylococcus Aureus

Tharmalingam, N., Ribeiro, N. Q., da Silva, D. L., Naik, M. T., Cruz, L. B., Kim, W., Shen, S., dos Santos, J. D., Ezikovich, K., D’Agata, E. M. C., et al. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0544 · Cited by 28 · see citing works

Gold Nanoclusters as Nanoantibiotic Auranofin Analogues

Ndugire, W., Raviranga, N. G. H., Lao, J., Ramström, O., & Yan, M. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101032 · Cited by 27 · see citing works

Auranofin and its analogs as prospective agents for the treatment of colorectal cancer

Massai, L., Cirri, D., Marzo, T., & Luigi Messori, A. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.71 · Cited by 27 · see citing works

Current and promising pharmacotherapeutic options for candidiasis

Scorzoni, L., Fuchs, B. B., Junqueira, J. C., & Mylonakis, E. E. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1873951 · Cited by 28 · see citing works

Antimicrobial Resistance of Neisseria gonorrhoeae in Sub-Saharan Populations

Yakobi, S. H., & Pooe, O. J. (2022) · Bacteria · doi:10.3390/bacteria1020009 · Cited by 25 · see citing works

High Efficiency Drug Repurposing Design for New Antifungal Agents

Jong Heon, K. I. M., Chan, K. L., Cheng, L. W., Tell, L. A., Byrne, B. A., Clothier, K. A., & Land, K. M. (2019) · Methods and Protocols · doi:10.3390/mps2020031 · Cited by 24 · see citing works

Repurposing of respiratory drug theophylline againstCandida albicans: mechanistic insights unveil alterations in membrane properties and metabolic fitness

Singh, S. V., Fatima, Z., Ahmad, K., & Hameed, S. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14669 · Cited by 24 · see citing works

Dispiropyrrolidine tethered piperidone heterocyclic hybrids with broad-spectrum antifungal activity against Candida albicans and Cryptococcus neoformans

Lawson, S., Arumugam, N., Almansour, A. I., Kumar, R. S., & Thangamani, S. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103865 · Cited by 22 · see citing works

Target‐based drug repurposing against Candida albicans —A computational modeling, docking, and molecular dynamic simulations study

Verma, R., Pradhan, D., Nayek, A., Singh, H., Jain, A. K., & Khan, L. A. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30163 · Cited by 19 · see citing works

Novel avenues for identification of new antifungal drugs and current challenges

Jampílek, J. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2097659 · Cited by 19 · see citing works

Organogold drug Auranofin exhibits anti-melanogenic activity in B16F10 and MNT-1 melanoma cells

Goenka, S., & Simon, S. R. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01974-1 · Cited by 19 · see citing works

Drug screens using the nematode Caenorhabditis elegans

Roy, P. J. (2025) · Genetics · doi:10.1093/genetics/iyaf141 · Cited by 18 · see citing works

Repurposing of auranofin and honokiol as antifungals against Scedosporium species and the related fungus Lomentospora prolificans

Yaakoub, H., Staerck, C., Mina, S., Godon, C., Fleury, M. J. J., Bouchara, J., & Calenda, A. (2021) · Virulence · doi:10.1080/21505594.2021.1909266 · Cited by 18 · see citing works

Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation

Chiaverini, L., Pratesi, A., Cirri, D., Nardinocchi, A., Tolbatov, I., Marrone, A., Luca, M. D., Marzo, T., & Mendola, D. L. (2022) · Molecules · doi:10.3390/molecules27082578 · Cited by 18 · see citing works

Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against C. albicans

Lin, J., Xiao, X., Liang, Y., Zhao, H., Yu, Y., Yuan, P., Lu, S., & Ding, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1065962 · Cited by 18 · see citing works

Redox-Based Strategies against Infections by Eukaryotic Pathogens

Vallières, C., Golinelli‐Cohen, M., Guittet, O., Lepoivre, M., Huang, M., & Vernis, L. (2023) · Genes · doi:10.3390/genes14040778 · Cited by 18 · see citing works

Screening of Natural Products and Approved Oncology Drug Libraries for Activity against Clostridioides difficile

Pal, R., & Seleem, M. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-63029-0 · Cited by 18 · see citing works

Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19

Das, R., Kotra, K., Singh, P., Loh, B., Leptihn, S., & Bajpai, U. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00559-8 · Cited by 17 · see citing works

Atazanavir Resensitizes Candida auris to Azoles

Elgammal, Y., Salama, E. A., & Seleem, M. N. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01631-22 · Cited by 17 · see citing works

Identification of Promising Antifungal Drugs against Scedosporium and Lomentospora Species after Screening of Pathogen Box Library

Rollin‐Pinheiro, R., Borba-Santos, L. P., Xisto, M. I. D. D. S., de Castro-Almeida, Y., Rochetti, V. P., Rozental, S., & Barreto‐Bergter, E. (2021) · Journal of Fungi · doi:10.3390/jof7100803 · Cited by 16 · see citing works

In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus

Chen, P., Yang, J., Jin, Y., Lu, C., Feng, Z., Gao, F., Chen, Y., Wang, F., Shang, Z., & Lin, W. (2023) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2023.101381 · Cited by 14 · see citing works

An Update on the Global Treatment of Invasive Fungal Infections

Munzen, M. E., Garcia, A. D. G., & Martinez, L. R. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0269 · Cited by 15 · see citing works

Future perspectives for cryptococcosis treatment

Santos-Gandelman, J. F., Rodrigues, M. L., & Silva, A. M. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1503252 · Cited by 14 · see citing works

Auranofin coated catheters inhibit bacterial and fungal biofilms in a murine subcutaneous model

LewisOscar, F., Whitely, C. B., Tharmalingam, N., Mishra, B., Vera‐González, N., Mylonakis, E. E., Shukla, A., & Fuchs, B. B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1135942 · Cited by 13 · see citing works

Anti-inflammatory drugs as potential antimicrobial agents: a review

Okpala, O. E., Rondevaldová, J., & Kokoška, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1557333 · Cited by 13 · see citing works

Antifungal activity of a maleimide derivative: disruption of cell membranes and interference with iron ion homoeostasis

Chen, C., Xie, Z., Liu, C., Mao, S., Wang, L., Wu, Y., Zhang, Y. L., Zhou, Q., Ahmad, A., Chang, W., et al. (2024) · Mycology&#58 An International Journal on Fungal Biology · doi:10.1080/21501203.2024.2330403 · Cited by 12 · see citing works

Synthesis of new pyrazolo[5,1-c][1,2,4]triazines with antifungal and antibiofilm activities

Al‐Trawneh, S. A., Al-Dawdieh, S. A., Abutaleb, N. S., Tarawneh, A. H., Salama, E. A., El‐Abadelah, M. M., & Seleem, M. N. (2019) · Chemical Papers · doi:10.1007/s11696-019-00974-9 · Cited by 12 · see citing works

Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer’s disease

Kushawaha, S. K., Ashawat, M. S., Soni, D., Kumar, P., Rimpi, & Baldi, A. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148906 · Cited by 11 · see citing works

Auranofin-loaded PLGA nanoparticles alleviate cognitive deficit induced by streptozotocin in rats model: modulation of oxidative stress, neuroinflammatory markers, and neurotransmitters

Kushawaha, S. K., Ashawat, M. S., & Baldi, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03253-x · Cited by 11 · see citing works

New 4,5-Diarylimidazol-2-ylidene–iodidogold(I) Complexes with High Activity against Esophageal Adenocarcinoma Cells

Schleser, S. W., Ghosh, H., Hörner, G., Seib, J., Bhattacharyya, S., Weber, B., Schobert, R., Dandawate, P. R., & Biersack, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065738 · Cited by 9 · see citing works

Thioredoxin Reductase 1 Is a Highly Immunogenic Cell Surface Antigen in Paracoccidioides spp., Candida albicans, and Cryptococcus neoformans

de Oliveira, F. F. M., Paredes, V., de Sousa, H. R., Moura, Á. N. D., Riasco-Palacios, J., Casadevall, A., Felipe, M. S. S., & Nicola, A. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02930 · Cited by 8 · see citing works

Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies

e Silva, D. M., de Souza Lacerda, L., de Souza Andrioli, A., Braz, W. R., Campos, L. M., de Paiva, M. R. B., Pittella, F., Fabri, R. L., & Tavares, G. D. (2025) · Fundamental &amp; Clinical Pharmacology · doi:10.1111/fcp.70046 · Cited by 7 · see citing works

Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin

Ma, J., van de Sande, W. W. J., & Biersack, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167909 · Cited by 6 · see citing works

Encephalitozoon intestinalis: A new target for auranofin in a mice model

Abou-El-Naga, I. F., Gaafar, M. R., Gomaa, M. M., Khedr, S. I., & Achy, S. E. (2019) · Medical Mycology · doi:10.1093/mmy/myz126 · Cited by 6 · see citing works

Whole-Genome Approach to Understanding the Mechanism of Action of a Histatin 5-Derived Peptide

Bullock, C. B., McNabb, D. S., & Pinto, I. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01698-19 · Cited by 6 · see citing works

Drug Discovery and Repurposing for Coccidioides: A Systematic Review

Saeger, S., Lozano, S., Wiederhold, N. P., Yu, J., Lopez-Ribot, J. L., & Hung, C.-Y. (2025) · Journal of Fungi · doi:10.3390/jof11120875 · Cited by 5 · see citing works

Discovery of spirooxindole-pyrrolidine heterocyclic hybrids with potent antifungal activity against fungal pathogens

Dowdy, H., Kumar, R. S., Almansour, A. I., Arumugam, N., Alaqeel, S. I., & Thangamani, S. (2022) · Pathogens and Disease · doi:10.1093/femspd/ftac013 · Cited by 5 · see citing works

CHCHD4 Oxidoreductase Activity: A Comprehensive Analysis of the Molecular, Functional, and Structural Properties of Its Redox-Regulated Substrates

Balasco, N., Modjtahedi, N., Monti, A., Ruvo, M., Vitagliano, L., & Doti, N. (2025) · Molecules · doi:10.3390/molecules30102117 · Cited by 5 · see citing works

A Periodic Table for Life and Medicines

Needham, R. J., & Sadler, P. J. (2019) · Structure and bonding · doi:10.1007/430_2019_51 · Cited by 5 · see citing works

Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs

Mohammad, H. T., Abutaleb, N. S., Dieterly, A. M., Lyle, L. T., & Seleem, M. N. (2021) · Scientific Reports · doi:10.1038/s41598-021-90360-x · Cited by 5 · see citing works

An overview to drug repurposing

Khambhati, K., Alessa, A. H., & Singh, V. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.026 · Cited by 5 · see citing works

Current and emerging therapies for fungal biofilms and systemic infections

Elgammal, Y., Martinez, R. I. G., Requejo, A., & Martinez, L. R. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2570185 · Cited by 4 · see citing works

Auranofin-loaded PLGA Nanoparticles for Neuroprotection against Aluminium-induced Alzheimer’s Disease

Kushawaha, S. K., Ashawat, M. S., Arora, R., & Baldi, A. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128336703241202182209 · Cited by 4 · see citing works

Auranofin is active against Histoplasma capsulatum and reduces the expression of virulence-related genes

Almeida, M. D. A., Baeza, L. C., da Silva, L. B. R., Bernardes‐Engemann, A. R., Almeida‐Silva, F., Coelho, R. A., de Andrade, I. B., Corrêa-Junior, D., Frasés, S., Zancopé‐Oliveira, R. M., et al. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012586 · Cited by 3 · see citing works

Assessing the Anti-Cryptococcus Antifungal Potential of Artemisinin

Maliehe, M., Albertyn, J., & Sebolai, O. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209953 · Cited by 3 · see citing works

Drug Repurposing in Search of Anti-Infectives: Need of the Hour in the Multidrug Resistance Era!

Sahu, N. U., Shah, C. P., Machhar, J. S., & Kharkar, P. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00014-6 · Cited by 3 · see citing works

Repurposing Drugs for Fungal Infections: Advantages and Limitations

Almeida‐Paes, R., & Frasés, S. (2023) · Future Microbiology · doi:10.2217/fmb-2023-0108 · Cited by 3 · see citing works

Auranofin and iodoquinol as promising repurposing drugs against filamentous fungi: antifungal activity and cellular alterations

Xisto, M. I. D. D. S., Rollin‐Pinheiro, R., da Rosa, P. C. M., Santos, J. D. S., Irmão, N. F. D. S., Abib, J. A. A., Rochetti, V. P., de Castro-Almeida, Y., Freitas, G. M. P. D. S., Cypriano, J. B. S., et al. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03356-25 · Cited by 2 · see citing works

Discovery of diazahexa/hepta cyclic cage-like compounds with broad-spectrum antifungal activity against Candida and Cryptococcus species

Weinstock, A., Arumugam, N., Almansour, A. I., Kumar, R. S., & Thangamani, S. (2019) · RSC Advances · doi:10.1039/c9ra05777c · Cited by 2 · see citing works

Formulation by Design-based Development and Characterization of Auranofin-loaded Nanoparticles for Brain Targeting

Kushawaha, S. K., Ashawat, M. S., & Baldi, A. (2026) · BioNanoScience · doi:10.1007/s12668-025-02400-9 · Cited by 1 · see citing works

Biofilms et rhumatismes inflammatoires chroniques

Berthelot, J., Darrieutort‐Laffite, C., Goff, B. L., Corvec, S., & Maugars, Y. (2020) · Revue du Rhumatisme · doi:10.1016/j.rhum.2020.06.002

Faculty Opinions recommendation of Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System.

Singh, U., & Kangussu-Marcolino, M. M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732876734.793546614

Aspergillus Therapeutics: Future Agents

Bansal, Y., Kundu, R., & Singla, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_15

Large-Scale Phenotypic Screenings of Repurposing Libraries to Identify Drugs with Novel Antifungal Activity Against Candida Biofilms

Rodríguez, A. V., Rodrigues, C. F., Ramage, G., & Lopez-Ribot, J. L. (2025) · Springer series on biofilms · doi:10.1007/978-3-031-93315-8_12

Biotransformations, dégradation et cycle de vie des nanoparticules d'or en milieu intracellulaire

Balfourier, A. (2019) · doi:10.70675/90ec2d90zc126z4d6dza795z0c214cc44684

Cascading damage to Candida albicans cells through thioredoxin reductase loss

Qi, W., Roy, U., Cai, C., Acosta‐Zaldívar, M., Mascio, J., Asara, J. M., Fierro, J. F., Andrés, M. T. A., Sun, L., & Köhler, J. R. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2615451123

Stress-dependent ribosome-associated proteomics reveals a role for Sis1 in thermotolerance and virulence in Cryptococcus neoformans

Mazzaferro, M. F., Benedetto, A. C., Bloom, A. L. M., Singh, P., Shen, S., Qu, J., & Panepinto, J. C. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00104-26

BindingDB Entry 50002345: Emerging New Targets for the Treatment of Resistant Fungal Infections.

BindingDB (2020) · UC San Diego · doi:10.7270/q26112x4

Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi

Wiederhold, N. P., Patterson, T. F., Srinivasan, A., Chaturvedi, A. K., Fothergill, A. W., Wormley, F. L., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2016) · Virulence · doi:10.1080/21505594.2016.1196301 · Cited by 88 · see citing works

Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin

Ma, J., van de Sande, W. W. J., & Biersack, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167909 · Cited by 6 · see citing works

Inhibition of Bacterial and Fungal Pathogens by the Orphaned Drug Auranofin

Fuchs, B. B., Rajamuthiah, R., Souza, A. C. R., Eatemadpour, S., Rossoni, R. D., Santos, D. A., Junqueira, J. C., Rice, L. B., & Mylonakis, E. E. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.182 · Cited by 62 · see citing works

In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus

Chen, P., Yang, J., Jin, Y., Lu, C., Feng, Z., Gao, F., Chen, Y., Wang, F., Shang, Z., & Lin, W. (2023) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2023.101381 · Cited by 14 · see citing works

Study on the potential for the repositioning of auranofin in the control of Candida albicans infections

Vegian, M. R. D. C. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)